Peng Zhang

发表

Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.

X. Liao, Yibin Wang, Hongliang Li, 2020, Hypertension.

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis

Feng Li, Hongliang Li, Xinliang Ma, 2017, Nature Medicine.

Exacerbating Pressure Overload–Induced Cardiac HypertrophyNovelty and Significance

Hongliang Li, Xue-Hai Zhu, Xiang Wei, 2015 .

Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.

Haibo Xu, Yibin Wang, Hongliang Li, 2021, Cell metabolism.

Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients

Qingbo Xu, G. Condorelli, P. Ye, 2021, Med.

Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.

Hongliang Li, Ling Huang, Xiao-Jing Zhang, 2015, Clinical science.

NAFLD as a continuous driver in the whole spectrum of vascular disease.

Hongliang Li, Jingjing Cai, Xiao-Jing Zhang, 2021, Journal of molecular and cellular cardiology.

F‐box/WD Repeat‐Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal‐Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice

Hongliang Li, Zhi‐Gang She, Ye Liu, 2019, Hepatology.

Tollip is a critical mediator of cerebral ischaemia–reperfusion injury

Sen Guo, Hongliang Li, Peng Zhang, 2015, The Journal of pathology.

A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques

R. Touyz, Haibo Xu, Hongliang Li, 2021, Science Translational Medicine.

Oncostatin M Confers Neuroprotection against Ischemic Stroke

H. Lei, Sen Guo, Hongliang Li, 2015, The Journal of Neuroscience.

Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2020, Circulation research.

Tumor Necrosis Factor Receptor–Associated Factor 3 Is a Positive Regulator of Pathological Cardiac Hypertrophy

Lu Gao, Hongliang Li, D. Jiang, 2015, Hypertension.

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Hepatology.

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Hongliang Li, Aibing Wang, Mei Xiang, 2016, Journal of hepatology.

Heavy Disease Burden of High Systolic Blood Pressure During 1990-2019: Highlighting Regional, Sex, and Age Specific Strategies in Blood Pressure Control

Hongliang Li, Jingjing Cai, Zhibing Lu, 2021, Frontiers in Cardiovascular Medicine.

Vinexin‐β deficiency protects against cerebral ischaemia/reperfusion injury by inhibiting neuronal apoptosis

Sen Guo, Hongliang Li, Peng Zhang, 2015, Journal of neurochemistry.

Epidemiological Features of NAFLD From 1999 to 2018 in China

Hongliang Li, Jingjing Cai, Jianghua Zhou, 2020, Hepatology.

Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

R. Touyz, Hongliang Li, Jingjing Cai, 2021, Science Translational Medicine.

Interferon regulatory factor 9 is critical for neointima formation following vascular injury

De-Pei Liu, Lu Gao, Hongliang Li, 2014, Nature communications.

Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD

Hongliang Li, Zan Huang, Jie Yu, 2021, Hepatology.

Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19

P. Ye, R. Touyz, G. Akolkar, 2020, Hypertension.

Zhang et al IRF Signalings in Cardiometabolic Diseases

Hongliang Li, Xiao-Jing Zhang, Peng Zhang, 2022 .

Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation

Weiqi Wang, Peng Zhang, Zhinan Mei, 2020 .

Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production

R. Touyz, Hongliang Li, A. Montezano, 2020, Hypertension.

Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice

Feng Li, Zan Huang, Aibing Wang, 2019, Hepatology.

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Hong Jin, Zhi‐Ren Zhang, Hongliang Li, 2016, Journal of hepatology.

Reply to: "Interferon regulatory factor 9 plays a dual function in health and disease".

Hongliang Li, Xiao-Jing Zhang, Peng Zhang, 2015, Journal of hepatology.

TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.

Haibo Xu, Hongliang Li, Jingjing Cai, 2020, Cell metabolism.

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

Hongliang Li, Aibing Wang, Xiao-Jing Zhang, 2016, Journal of hepatology.

Reprogramming Innate Immune Signaling in Cardiometabolic Disease

Hongliang Li, Xiao-Jing Zhang, Peng Zhang, 2017, Hypertension.

High Remnant Cholesterol Level Potentiates the Development of Hypertension

G. Wang, Hongliang Li, Zhi‐Gang She, 2022, Frontiers in Endocrinology.

STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy

Hongliang Li, Zan Huang, Zhi‐Gang She, 2020, Hypertension.

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

P. Ye, Jing Xie, J. Chen, 2020, Hepatology.

Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy

Hongliang Li, Zhi‐Gang She, Peng Zhang, 2017, Circulation.

Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes

Hongliang Li, Jingjing Cai, Yufeng Yuan, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

DMSO_A_332819 4469..4482

Hongliang Li, Jingjing Cai, Yufeng Yuan, 2021 .

Tripartite motif‐containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin‐proteasome–mediated degradation of pleckstrin homology domain leucine‐rich repeats protein phosphatase 1

Li Zhang, Xu Cheng, Peng Zhang, 2022 .

Response by Zhang et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”

Yibin Wang, Hongliang Li, Jingjing Cai, 2020, Circulation research.

Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway

Jia Liu, Zhi‐Gang She, Shuyan Li, 2018, Journal of the American Heart Association.

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity

Hongliang Li, Zhibing Lu, Fang Lei, 2020, Journal of the American Heart Association.

Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2)

Hongliang Li, Xiang Wei, Xiao-Jing Zhang, 2017, Hypertension.

Neuron-Specific Tumor Necrosis Factor Receptor–Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke

Lu Gao, Sen Guo, Hongliang Li, 2015, Hypertension.

Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2020, Hepatology.

Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta–Activated Kinase 1–c‐Jun‐N‐Terminal Kinase/p38 Signaling

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2020 .

Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD

Hongliang Li, Zhi‐Gang She, Xu Cheng, 2021, Hepatology.

Mindin deficiency protects the liver against ischemia/reperfusion injury.

Hongliang Li, Peng Zhang, S. Tian, 2015, Journal of hepatology.

Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.

Zan Huang, Yufeng Yuan, Zhi‐Gang She, 2022, Journal of hepatology.

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Qingbo Xu, J. Xie, P. Ye, 2020, Circulation research.

Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis

Hongliang Li, Jingjing Cai, Jianghua Zhou, 2019, Hepatology.

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Lu Gao, Hongliang Li, Xiao-Jing Zhang, 2016, Journal of hepatology.

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

P. Zhang, D. Srivastava, Yen-Sin Ang, 2016 .

Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator‐Activated Receptor γ in Mice

Hongliang Li, Jingjing Cai, Zan Huang, 2019, Hepatology.

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Qingbo Xu, P. Ye, Yibin Wang, 2020, Cell Metabolism.

A risk score based on baseline risk factors for predicting mortality in COVID-19 patients

G. Condorelli, P. Ye, Yibin Wang, 2021, Current medical research and opinion.

TNFAIP3 Interacting Protein 3 Is an Activator of Hippo‐YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury

Hongliang Li, Zhi‐Gang She, Xu Cheng, 2021, Hepatology.

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19

Yibin Wang, X. Liao, J. Xia, 2021, Cell Metabolism.

Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities

Yufeng Yuan, Zhi‐Gang She, Xiao-Jing Zhang, 2021, Journal of Infection and Public Health.

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling

Hongliang Li, Sijun Yang, Xiao-Jing Zhang, 2016, Nature Communications.

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Fang Lei, Jiao Guo, Peng Zhang, 2020, Cell Metabolism.

Interferon Regulatory Factor 7 Protects Against Vascular Smooth Muscle Cell Proliferation and Neointima Formation

Lu Gao, Hongliang Li, Ling Huang, 2014, Journal of the American Heart Association.

Perioperative Presentation of COVID‐19 Disease in a Liver Transplant Recipient

Hongliang Li, Jingjing Cai, Yufeng Yuan, 2020, Hepatology.

Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2021, Frontiers in Medicine.

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling

Hongliang Li, Zan Huang, Xiao-Jing Zhang, 2016, Nature Communications.

Interferon Regulatory Factor Signalings in Cardiometabolic Diseases

Hongliang Li, Xiao-Jing Zhang, Peng Zhang, 2015, Hypertension.

Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.

Jingjing Cai, Zhi‐Gang She, Feng Zhou, 2021, Cell metabolism.

Hepatic Regulator of G protein Signaling 5 Ameliorates NAFLD by Suppressing TAK1-JNK/p38 Signaling.

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2020, Hepatology.

Interferon Regulatory Factor 4 Inhibits Neointima Formation by Engaging Krüppel-Like Factor 4 Signaling

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Circulation.

Interferon regulatory factor 9 is critical for neointima formation following vascular injury

De-Pei Liu, Lu Gao, Hongliang Li, 2014, Nature Communications.

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Nature Medicine.

Reply:

Hongliang Li, Jingjing Cai, Jianghua Zhou, 2019, Hepatology.

A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis.

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Cell metabolism.

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

P. Ye, Yibin Wang, Jingjing Cai, 2020, Cell Metabolism.

An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury

Hongliang Li, Xinliang Ma, Zan Huang, 2017, Nature Medicine.

FASN-suppressor screening identifies SNX8 as a novel therapeutic target for NAFLD.

Hongliang Li, Zan Huang, Jie Yu, 2021, Hepatology.

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy

Hongliang Li, Aibing Wang, Xue-Hai Zhu, 2016, Nature Communications.

A conventional immune regulator mitochondrial antiviral signaling protein blocks hepatic steatosis by maintaining mitochondrial homeostasis

Hongliang Li, Chongshu Jian, Jingwei Jiang, 2021, Hepatology.

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4

Hongliang Li, Zan Huang, Zhi‐Gang She, 2017, Nature Medicine.

Exacerbating Pressure Overload-Induced Cardiac Hypertrophy: Novel Role of Adaptor Molecule Src Homology 2-B3.

Hongliang Li, Xue-Hai Zhu, Xiang Wei, 2015, Hypertension.

Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3

Tianyu Li, Xu Cheng, Xiang Wei, 2020, Hepatology.

The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Hepatology.

TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease.

Hongliang Li, Yufeng Yuan, Zhi‐Gang She, 2021, Cell metabolism.

Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator‐Activated Receptor γ in Mice

Hongliang Li, Jingjing Cai, Zan Huang, 2019, Hepatology.

Attenuation of cerebral ischemic injury in interferon regulatory factor 3‐deficient rat

Sen Guo, Hongliang Li, J. Qin, 2016, Journal of neurochemistry.

Hepatocyte SH3RF2 Deficiency is a Key Aggravator for Nonalcoholic Fatty Liver Disease.

Hongliang Li, Zhi‐Gang She, Xu Cheng, 2021, Hepatology.

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

D. Srivastava, Yen-Sin Ang, X. Xiao, 2016, Nature Medicine.

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Lu Gao, Hongliang Li, Xiao-Jing Zhang, 2016, Journal of hepatology.

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

Hongliang Li, Aibing Wang, Xiao-Jing Zhang, 2016, Journal of hepatology.

A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy

D. Srivastava, Yen-Sin Ang, X. Xiao, 2016, Nature Medicine.

F‐box/WD Repeat‐Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal‐Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice

Hongliang Li, Zhi‐Gang She, Ye Liu, 2019, Hepatology.

Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation

Peng Zhang, Zhinan Mei, Hui Xiong, 2020, Hepatology.

Exacerbating Pressure Overload – Induced Cardiac Hypertrophy Novel Role of Adaptor Molecule Src Homology 2-B 3

Xue-Hai Zhu, D. Jiang, Peng Zhang, 2015 .

Milk Fat Globule–Epidermal Growth Factor–Factor 8 Improves Hepatic Steatosis and Inflammation

Hongliang Li, Jingjing Cai, Zhi‐Gang She, 2020, Hepatology.

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Hong Jin, Zhi‐Ren Zhang, Hongliang Li, 2016, Journal of hepatology.